- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01960569
Topical r-Hirudin ( Thrombexx ) Efficacy in Treatment of Haematomas
Single Centre,Randomized,Phase IV Study to Assess the Topical r-Hirudin (Thrombexx)Efficacy in the Patients With Haematomas
Single centre ,Phase IV , interventional, The study includes :
200 patients, 100 Patients will have Topical r-Hirudin (Thrombexx) and 100 patients will have placebo .
The patients will be randomized to the active product (arm 1) or to placebo (arm 2).
The study consists of 4 visits as the following :
- Visit 1 : on day 1 to check patient eligibility and also for randomization .
- Visit 2 : on day 4 to assess target parameters
- Visit 3 : on day 8 to assess target parameters
- Visit 4 : on day 16 to assess target parameters
Study Overview
Status
Intervention / Treatment
Detailed Description
Single centre ,Phase IV , interventional, The study includes :
* 200 patients, 100 Patients will have Topical r-Hirudin (Thrombexx) and 100 patients will have placebo .
The patients will be randomized to the active product (arm 1) or to placebo (arm 2).
The study consists of 4 visits as the following :
- Visit 1 : on day 1 to check patient eligibility and also for randomization .
- Visit 2 : on day 4 to assess target parameters
- Visit 3 : on day 8 to assess target parameters
Visit 4 : on day 16 to assess target parameters
- Study objective :Assessment the Efficacy of Topical r-Hirudin in treatment of haematomas ,also in resolving of the associated oedema
- Study duration : 6 months
- Selection of trial subjects:
Inclusion Criteria :
- Age of patients between 20 and 60 years old.
- Patients with all types of haematomas.
Exclusion Criteria:
- Presence of infected wound requiring hospitalization or surgical intervention.
- History of allergy or hypersensitivity to any of the ingredients.
- Patients with coagulation disorders like haemophilia.
- Patients who are on anticoagulants like Warfarin and Acetylsalicylic acid .
Patients who are taking digestive enzymes like alfa chemotrypsin.
- Target parameters :
1.Size of haematoma.( Measured by ruler) , The ruler will measure the longest 2 intersecting line.
2.Size of oedema : by measurement of oedema circumference
3.Pain (by Vas score).
4.Change in colour ( by colour grade scale ) .
Study Type
Enrollment (Anticipated)
Phase
- Phase 4
Contacts and Locations
Study Contact
- Name: Mahmoud Hafez, Professor
- Phone Number: 002 0100 7566299
- Email: mhafez@msn.com
Study Contact Backup
- Name: Moustafa Sameer, Dr
- Phone Number: 002 0100 6016 212
- Email: msameer@minapharm.com
Study Locations
-
-
-
Cairo, Egypt
- Recruiting
- Prof. Mahmoud Hafez
-
Contact:
- Ahmed Moneer, Dr
- Phone Number: 002 0100 8608676
- Email: dr_ahmedmoneer@yahoo.com
-
Principal Investigator:
- Mahmoud Hafez, Professor
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age of patients between 20 and 60 years old.
- Patients with all types of haematoma.
Exclusion Criteria:
- Presence of infected wound requiring hospitalization or surgical intervention.
- History of allergy or hypersensitivity to any of the ingredients.
- Patients with coagulation disorders like haemophilia.
- Patients who are on anticoagulants like Warfarin and Acetylsalicylic acid .
- Patients who are taking digestive enzymes like alfa chemotrypsin.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Arm 1 : active product (Thrombexx)
100 patients will have the active product(Thrombexx), their visits on days 1,4,8 and 16 for target parameters assessment
|
Dispense 2-3 cm of cream or gel, 2-3 times per day and carry out a light massage until complete
Other Names:
|
PLACEBO_COMPARATOR: Arm 2 : Placebo
100 patients will have placebo , their visits on days 1,4,8 and 16 for target parameters assessment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Size of haematoma
Time Frame: 6 months
|
Assessment the size of haematoma will be by ruler with unit centimeter(cm) , The ruler will measure the longest 2 intersecting line.
|
6 months
|
Size of oedema
Time Frame: 6 months
|
Assessment the size of oedema will be by measurement the circumference in unit centimeter(cm).
|
6 months
|
Severity of Pain
Time Frame: 6 months
|
Assessment of pain severity will be by Vas score
|
6 months
|
Change in Colour
Time Frame: 6 months
|
Assessment of colour will be by colour grade scale , A=Bluish red , B=Blue ,C= Faint
|
6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Mahmoud Hafez, Professor, 6th october university
- Study Chair: Ahmed Moneer, Dr, 6th october university
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Minpharm07052012
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on r-Hirudin (Thrombexx) Efficacy in Treatment of Haematomas
-
Second Affiliated Hospital, School of Medicine,...First Affiliated Hospital of Jinan University; First Affiliated Hospital of... and other collaboratorsRecruitingEvaluate the Efficacy of Cyclical Topical Wound Oxygen Therapy in the Treatment of Chronic WoundsChina
-
Sun Yat-sen UniversityCompletedEfficacy of Exclusive Enteral Nutrition in Adult Active Crohn's Disease With Complications or Failure of Medical TreatmentChina
-
Shandong New Time Pharmaceutical Co., LTDCompletedA Phase IV Trial to Investigate the Efficacy and Safety of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty LiverChina
-
Cairo UniversityRecruitingTecar Therapy Efficacy in the Treatment of PDPHEgypt
-
Chittagong Medical CollegeCompletedTo See the Safety and Efficacy of the Topical Latanoprost Compared With Topical Brimonidine in the Treatment of the Primary Open Angle Glaucoma PatientsBangladesh
-
Institut fuer FrauengesundheitNovartis; ClinSolUnknownis to Identify Biomarkers That Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients.Germany
-
Yanbing LiNot yet recruitingEfficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM Patients | Metformin Combined With Insulin Glargine in the Treatment of Type 2 Diabetes Patients Who Still Have Poor Hypoglycemic Effect | 128 Patients Were Randomly Assigned 1:1 | Metformin and Insulin Glargine Combined... and other conditionsChina
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingTo Evaluate the Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer
-
Fudan UniversityCompletedTHE Efficacy and Safety of Gemcitabine in the Maintenance Treatment of Advanced Non-small Cell Lung CancerChina
-
General Administration of Military Health, TunisiaRecruitingStudy the Efficacy of ITA in Patients With Allergic Asthma or Allergic Rhinitis or Allergic Rhinitis Compared With Conventional TreatmentTunisia
Clinical Trials on active product ( Thrombexx) assigned to arm 1
-
Hospital de Clinicas CaracasUnknownPolycystic Ovary Syndrome (PCOS) WomenVenezuela
-
Radicle ScienceActive, not recruitingRadicle Recharge: A Study of Health and Wellness Products on Energy Levels and Other Health OutcomesFatigue | EnergyUnited States
-
Morehouse School of MedicineNational Cancer Institute (NCI)UnknownColorectal CancerUnited States
-
Vanderbilt UniversityAmerican Association of Diabetes EducatorsCompletedDiabetesUnited States
-
Diakonhjemmet HospitalOslo University HospitalCompleted
-
University of California, BerkeleyNational Institute of Mental Health (NIMH); Health for a Prosperous Nation; R... and other collaboratorsCompletedHIV/AIDS | Adherence, Medication | Adherence, PatientTanzania
-
Radicle ScienceActive, not recruitingFatigue | EnergyUnited States
-
Radicle ScienceCompletedDepression | Pain | Sleep | AnxietyUnited States
-
Radicle ScienceRecruitingPain | Neuropathic Pain | Nociceptive PainUnited States
-
Radicle ScienceActive, not recruitingSleep Disorder | Sleep | Sleep DisturbanceUnited States